AI Tool Slashes Pharma Video Production from Weeks to Hours

LONDON, UK – April 16, 2026 – A new artificial intelligence platform is poised to dismantle a long-standing bottleneck in the pharmaceutical industry, promising to transform a process that takes weeks and costs tens of thousands of dollars into a task completed in mere hours. Visual Pharma by Powtoon has been named a finalist in the prestigious 2026 LTEN Excellence Awards for its MOA Studio, an AI-powered workflow that automates the creation of complex scientific animations.

The nomination in the Innovative Design & Solutions category recognizes the platform's potential to fundamentally alter how pharmaceutical companies communicate complex science. For decades, creating Mechanism-of-Action (MOA) videos—visuals that explain how a drug works at a molecular level—has been a slow, costly, and resource-intensive endeavor, limiting the agility of medical and marketing teams. Powtoon's solution aims to change that paradigm by placing a powerful, compliant content creation engine directly into the hands of pharmaceutical professionals.

Ending a Costly Production Bottleneck

For anyone in pharmaceutical marketing or medical affairs, the traditional process of creating an MOA video is painfully familiar. It begins with a lengthy brief, followed by a multi-stage engagement with an external creative agency. The timeline, according to industry benchmarks, typically stretches anywhere from four to sixteen weeks. This process involves extensive scriptwriting, storyboarding, 3D modeling, animation, and multiple rounds of intense review by medical, legal, and regulatory (MLR) teams.

The financial burden is equally significant, with costs for a single high-quality video asset often reaching tens of thousands of dollars. This high barrier to entry means that such visual tools are often used sparingly, reserved only for the highest-priority products or launch campaigns. It also makes updating content with new clinical data a prohibitively expensive and slow process, hindering the flow of timely information to healthcare providers and internal teams.

MOA Studio directly confronts this challenge. By leveraging a purpose-built AI, the platform enables Medical Affairs and learning teams to generate scientifically grounded visual content from their clinical source documentation in a matter of hours. This dramatic acceleration in speed has a cascading effect on efficiency, promising significant cost reductions by minimizing reliance on external vendors and reducing the man-hours required for production and review. The result is not just a cost-saving measure, but a strategic advantage, enabling companies to be more nimble in their educational efforts and accelerate readiness for product launches.

The Compliant AI: Balancing Speed with Trust

In the highly regulated pharmaceutical sector, speed cannot come at the expense of accuracy or compliance. The risk of disseminating incorrect or non-compliant information is immense, carrying severe regulatory and reputational consequences. This is where MOA Studio's architecture aims to build confidence.

The platform is not a general-purpose generative AI. It is built on what the company calls a “structured AI framework” that is directly aligned with and trained on verified clinical source documentation. This ensures that the initial creative output is scientifically grounded from the start.

Crucially, the system embeds a human-in-the-loop (HITL) validation process. This model ensures that AI-generated content is always reviewed, edited, and approved by human experts—such as medical directors or regulatory specialists—before it is finalized. This critical step acts as a safeguard, combining the speed of machine generation with the nuanced judgment and accountability of human oversight. It directly addresses regulatory expectations from bodies like the FDA and EMA, which emphasize the need for transparency, validation, and control in any AI system used in healthcare.

Further reinforcing this commitment to regulatory alignment, the platform includes built-in compliance checkpoints, brand controls, and version-controlled audit trails. These features provide a complete, traceable history of every content asset from creation to approval, an essential requirement for any company operating under regulatory scrutiny. This auditable workflow is designed to give compliance officers and legal teams the assurance that the content being produced meets all necessary standards.

A Broader Shift in Life Sciences Communication

The recognition from the Life Sciences Trainers & Educators Network (LTEN) underscores the significance of this innovation beyond just marketing. The LTEN Excellence Awards are a premier program within the life sciences training community, with judging conducted by experienced industry leaders. A nomination validates the tool's potential to enhance learning and development for internal teams, such as sales representatives and Medical Science Liaisons, who need to deeply understand and communicate complex scientific narratives.

This development is emblematic of a wider trend of AI adoption across the pharmaceutical industry. As companies grapple with ever-increasing volumes of data and pressure to improve efficiency, AI is being deployed to streamline everything from drug discovery to clinical trial management. Powtoon's focus on the specific niche of compliant visual communication sets it apart in a growing field of AI vendors targeting the life sciences.

"This reflects a broader shift across pharma," said Ilya Spitalnik, CEO of Powtoon, in the company's announcement. "The challenge is no longer just creating content, it's enabling knowledge to move faster across teams, while maintaining the highest standards of scientific accuracy and compliance. MOA Studio was built to support exactly that."

By transforming dense clinical data into engaging, story-driven visuals, the technology aims to improve knowledge retention and engagement for both internal field teams and external healthcare audiences. The ability to rapidly update and disseminate scientific content as new evidence emerges could lead to a more dynamic and responsive educational ecosystem.

Winners of the LTEN Excellence Awards will be announced at the organization's annual conference in June. Powtoon is also scheduled to showcase MOA Studio at its Triple AI Unboxing event on May 20, signaling its continued investment in AI-driven solutions for enterprise communication.